2. AbbVie Inc. [ABBV]
Industry: Drug Manufacturers – General
Current price: $111.69 | 1 year: +15.81% | 5 years: +83.55%
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women’s health, oncology, and neuroscience. AbbVie also offers treatments for diseases including multiple sclerosis, parkinson’s, and alzheimer’s disease.
Abbvie has a market cap of $196.97 with an enterprise value of $275.33 billion. Their price to sales ratio is 4.30 and their price to book ratio is 15.07. It is trading at $111.69 with a 52-week high of $113.41 and a 52-week low of $79.11. Their profit margin is 10.08% and their operating margin is 34.27%. About management effectiveness, their return on assets is 8.19% and their return on equity is 187.70%. The stock has an average 10-day volume of $5.16 million with outstanding shares of $1.76 billion. They had revenue of $45.8 billion which equals a revenue per share of $27.48. They are sitting on total cash of $8.49 billion and they have an operating cash flow of $17.59. The statistics are looking very well for the company, which means Abbvie could be a good long-term option for investors.
Check out the latest forecasts and news about cryptocurrencies, stocks, forex pairs and more on WalletInvestor.com